| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T59 |
0-127 |
Sentence |
denotes |
Patient 1 (A) Before itolizumab (D0): diffuse Interstitial-alveolar infiltrate in both lung fields, predominantly in the bases. |
| T60 |
128-331 |
Sentence |
denotes |
Minor left pleural effusion. (B) After itolizumab (48 h): radiological improvement with decreased diffuse infiltrate and radio-opacity at the top of both lungs and in both lung bases, in less proportion. |
| T61 |
332-368 |
Sentence |
denotes |
The minor pleural effusion persists. |
| T62 |
369-641 |
Sentence |
denotes |
Patient 3 (C) Before itolizumab (D0): alveolar interstitial inflammatory infiltrate in both lung fields, predominantly on the right side. (D) After itolizumab (48 h): radiological improvement with significant decrease of the alveolar interstitial infiltrate of both lungs. |
